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Abstract 
Review on EDIL3, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: DEL1 
HGNC (Hugo): EDIL3 
Location: 5q14.3 
Note 
EDIL3 is developmentally regulated and expressed 
during embryogenesis. It is expressed in 
extraembryonic mesoderm, specifically the yolk sac 
blood islands. EDIL3 is detected in angioblasts and 
early endothelial cells in four developing organs: 
heart, lung, kidney, and eye. It is also expressed in 
hypertrophic chondrocytes. Additionally, EDIL3 
has a function that affects endocytosis, apoptosis, 
cell migration, or some combination thereof. 
DNA/RNA 
Note 
EDIL3 is an extracellular matrix protein that 
contains three EGF-like repeats and two discoidin 
I-like domains. The second EGF-like repeat 
contains an RGD integrin binding motif that 
appears to be a ligand for alpha-v beta-3 integrin 
receptor.  
Similarly, EDIL3 shares consensus sequences with 
the fate determining notch proteins and coagulation 
factor IX, coagulation factor V, and coagulation 
factor VIII. 
Description 
442.48 kb, mRNA: 2974 bp, 11 Exons. 
Transcription 
The major transcript is represented by the most 
common cDNA clones, and it encodes a 480 amino 
acid protein in human. The major transcript encodes 
a protein that consists of a signal peptide 
comprising three epidermal growth factor- (EGF)-
like repeats and two discoidin I-like domains. A 
less frequently represented minor transcript 
designated the minor transcript encodes a signal 
peptide comprising three EGF repeats and a portion 
of the amino-terminal discoidin I-like domain. 
There is additional complexity among other minor 
transcripts; specifically, the variation is in the 
inclusion or exclusion of sequences that encode 10 
amino acids in the spacer region between EGF1 and 
EGF2. 
Pseudogene 
Not known. 
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Protein 
Note 
EDIL3 contains three Ca-binding EGF-like repeats 
and two discoidin I-like domains. There is an 
integrin-binding site in the second EGF-like repeat; 
specifically, this EGF-like repeat has an RGD 
peptide that binds to integrin alpha v beta 3. 
Description 
EDIL3 has 480 amino acids, and its molecular 
weight is 52 kDa protein.  
EDIL3 comprises 480 amino acids, and its 
molecular weight is 52 kDa protein. 
- The domain of 1-23 is an initio prediction. The 
subsequent domain is 24-470 which EGF-like 
repeat and discoidin I-like domain-containing 
protein 3 isoform 2.  
The region name is EGF1 which Calcium-binding 
EGF-like domain, present in a large number of 
membrane-bound and extracellular proteins.  
- Location: 27-59; many of these proteins require 
calcium for their biological function and calcium-
binding sites.  
The region name is EGF2 which Calcium-binding 
EGF-like domain, present in a large number of 
membrane-bound and extracellular proteins.  
- Location: 69-107; Many of these proteins require 
calcium for their biological function and calcium-
binding sites.  
The region name is EGF3 which Calcium-binding 
EGF-like domain, present in a large number of 
membrane-bound and extracellular proteins.  
- Location: 109-145; many of these proteins require 
calcium for their biological function and calcium-
binding sites.  
- Location: 109112126; Ca2+ binding site.  
The region (147-304) name is FA58C which note - 
Coagulation factor 5/8 C-terminal domain, 
discoidin domain.  
The region name is FA58C which note - 
Coagulation factor 5/8 C-terminal domain, 
discoidin domain; Cell surface-attached 
carbohydrate-binding domain, present in eukaryotes 
and assumed to have horizontally transferred to 
eubacterial genomes (150-303), sugar binding site 
(196224231).  
The region (308-466) name is FA58C which note - 
Coagulation factor 5/8 C-terminal domain, 
discoidin domain.  
The region name is FA58C which note - 
Coagulation factor 5/8 C-terminal domain, 
discoidin domain; Cell surface-attached 
carbohydrate-binding domain, present in eukaryotes 
and assumed to have horizontally transferred to 
eubacterial genomes (311-465), sugar binding site 
(358386393). 
Expression 
EDIL3 is differentially expressed depending on the 
tissue and cell culture conditions. 
Organism parts: (see below).  
Kidney, myometrium, bone, spinal cord, stomach 
fundus, heart, colon cecum, urethra, islet of 
Langerhans, synovial membrane, lung, 
atherosclerotic aortic wall, internal mammary 
artery, liver tumor tissue, accumbens, amygdale, 
brain, caudate nucleus, central nervous system, 
cerebral cortex, colon mucosa, corpus callosum, 
dorsal root ganglion, frontal cortex, primary motor 
cortex, Brodmann's Area 4, frontal lobe, 
hippocampus, hypothalamus, medulla, midbrain, 
nodose nucleus, homogenized, occipital lobe, 
parietal lobe, putamen, saphenous vein, skin, 
substantia nigra, subthalamic nucleus, temporal 
lobe, testis, thalamus, trigeminal ganglion, 
umbilical cord, ventral tegmental area, vestibular 
nuclei superior, cervix, ovary, stomach, liver, 
smooth muscle.  
The above data derive from the EDIL3 entry in the 
Expression Atlas. 
Diseases: (see below) 
Breast carcinoma, sarcoma, Combined 
Hepatocellular Cholangiocarcinoma (CHC), 
Intrahepatic Cholangiocarcinoma (ICC), 
leiomyosarcoma, pituitary cancer, extranodal 
NK/T-cell lymphoma, osteosarcoma, 
undifferentiated sarcoma, invasive ductal 
carcinoma, mucosa-associated lymphoid tissue 
lymphoma, papillary thyroid carcinoma, peripheral 
T-cell lymphoma, pancreatic cancer, cervical 
cancer, clear cell renal carcinoma, engineered 
invasive esophageal squamous cell carcinoma, 
prostate carcinoma.  
The above data derive from the EDIL3 entry in the 
Expression Atlas.  
Cell lines: (see below) 
DU145, ACHN, CaOv3, Caki2, H460, HeLa, KG1, 
MDAMB231, GM10833, GM13883, HCC70, U87 
CuFi, U251, NCIH1623, SCC-25, 786-O, ITM, 
HCC-1428, HuNS1, AG10750, LNCAP, SW780, 
AG11498, KTCL26, NCIH1436, Capan2, 
GM10842, HMESO, SKRC54, UMRC3, 639V, 
A172, A7, Acute Lymphoblastic Leukemia cell line 
SEM-K2, BE2C, BHT101, BM1604, C32TG, C4II, 
CCFSTTG1, CESS, CGTHW1, CHP212, 
COLO320DM, COLO320HSR, COLO704, 
CORL279, CORL88, Calu1, D283Med, 
DBTRG05MG, DKMG, DMS114, DMS273, 
Detroit562, GDM1, GLI60 glioblastoma cell line, 
H1975, H4, H460a, HCC1143, HCC1395, 
HDMYZ, HOS, HT1080, HT3, HuPT4, IM9, 
KHOS240S, KU812, L591, MCF-
7/LTED,,MCF10-T1k (MII), MDA-MB-231, MT4, 
NCIH1048, NCIH1355, NCIH1395, NCIH1563,  
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NCIH1651, NCIH1694, NCIH1770, CIH1792, 
NCIH1975,NCIH1993, NCIH2009, NCIH2030 
,NCIH2052, NCIH2228, NCIH226, NCIH2347, 
NCIH358, NCIH446, NCIH524, NCIH69, 
NCIH716, NCIH748, NCIH810, NCIH82, OE21, 
PC-3, PC-3/Mc, RCC4, RDES, SCaBER, SHP77, 
SJRH30, SJSA1, SKLMS1, SKMES1, SKNEP1, 
SNB19, SNU18, 2SNU387, SNU423, SNU449, 
SNU475, SW1088, SW1353, SW1783, SW1990, 
SW756, SW900, SW954, SW982, T98G glioma, 
TaY-E10, UT-15, WI38, WM115, Y79, YPAC, 
A498, BT474, PC3, SKOV3, HL-60, A549. 
The above data derive from the EDIL3 entry in the 
Expression Atlas Expression Atlas. 
Function 
EDIL3 promotes adhesion of endothelial cells to 
extracellular matrix through interaction with the 
alpha-v/beta-3 integrin receptor. It inhibits the 
formation of vascular-like structures in vitro. 
Exogenous EDIL3 causes abnormal vasculature in 
chick embryos. Overexpression of EDIL3 decreases 
vasculature in mesenteric vessels. It may be 
involved in the regulation of vascular 
morphogenesis and remodeling during embryonic 
development. 
Reportedly, high expression of EDIL3 by cancer 
cells is an indicator of poor prognosis, possibly 
because EDIL3 can enhance vascular formation in 
hepatocellular carcinoma, colon cancer, and 
experimental models with an osteosarcoma cell line 
or with Lewis lung carcinoma. However, an EDIL3 
fragment containing the third EGF-like repeat 
induces apoptosis. In a mouse model of cancer 
involving an explanted tumor, gene therapy with 
DNA encoding a recombinant protein comprising 
the third EGF-like repeat and the first discoidin 1 
like domain efficiently induces apoptosis, reduces 
tumor growth, and improves prognosis. 
Homology 
The EGF repeats of EDIL3 are homologous to 
molecules such as Notch (Accession: 
NM_017617.3) and its ligands Crumbs (Accession: 
CH471090.1) and Delta (Accession: 
NT_033777.2). There is also considerable 
homology in this region to the following four other 
proteins: a developmental sea urchin protein 
fibropellin (Accession: NW_003578619.1); a factor 
shown to function in lineage commitment of 
adipocytes (Accession: NC_000003.11); an 
endothelial cell-specific receptor tyrosine kinase 
(Accession: NC_000070.6) known to be essential 
for embryonic blood vessel development; and 
coagulation factor IX (Accession: NM_000133), 
which has a role in the coagulation cascade. In its 
discoidin I-like domains, EDIL3 is homologous to 
five proteins: the mammary epithelial cell marker 
milk fat globule membrane protein (Accession: 
NC_000015.9), coagulation factors V (Accession: 
NC_000001.10) and VIII (Accession: 
NP_000123.1), the extracellular domain of a group 
of tumor-associated orphan receptor tyrosine 
kinases (Accession: Q01973, Q01974), and 
discoidin domain receptor tylosin kinase 
(Accession: AB_202100, BC_052998). 
Mutations 
Note 
Not known in human. 
Implicated in 
Hepatocellular carcinoma (HCC) 
Note 
When immunocytochemistry and tumor tissue 
samples from 101 patients with HCC were used to 
examine expression level of EDIL3 protein in 
HCCs, EDIL3 was detected in the cytoplasm of 
HCC cells. Overall, 95 (94.06%) of the 101 patients 
exhibited EDIL3-positive expression in the 
respective HCC samples, and 6 (5.94%) exhibited 
EDIL3-negative expression in the HCC samples. 
Among these 101 patients with HCC, 49 (48.5%) 
exhibited high levels of EDIL3 expression in 
normal somatic tissue, and 52 (51.5%) exhibited 
low levels of EDIL3 expression. The high 
expression level of EDIL3 protein in HCC samples 
was a significant prognostic factor for poor overall 
survival among patients with HCC. The 5-year 
survival rate among patients with HCC and a high 
or a low EDIL3 protein expression level was 32.4% 
and 53.2%, respectively. (Sun et al., 2010). 
Colon cancer 
Note 
Tumor tissues from 10 patients with colon cancer 
were immunostained with anti-Del1 antibody, and 
Del1 was found to be expressed in each colon 
cancer tissue sample (100%) at various levels. 
Using a mouse model of colon cancer involving 
explanted cells from a culture line, both Del1-
shRNA and VEGF-shRNA gene therapies showed a 
synergic effect in suppressing growth of explanted 
tumors by anti-angiogenesis and anti-proliferation. 
(Zou et al., 2009). 
Other tumors 
Note 
In cases of basal cell carcinoma or astrocytoma, 
Del1 expression was detected via 
immunohistochemistry, and Del1 expression was 
primarily evident in the matrix and basement 
membrane that surrounded tumor cells. Low-level 
Del1 staining was also evident over some of the cell 
bodies. Del1 signal was not detected in tumor-
associated endothelial cells.  
EDIL3 (EGF-Like Repeats And Discoidin I-Like Domains 3) Kitano H, Hidai C 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 18(11) 827 
A large percentage of cells in primary breast 
carcinomas, melanomas, and colon cancers in 
humans reportedly express Del1. Additionally, 
endothelial cells also reportedly express Del1 in 
these tumors. 
Aoka et al. have reported that Del1 accelerates 
tumor growth by enhancing vascular formation in a 
mouse explanted tumor model involving an 
osteosarcoma cell line (Aoka et al., 2002). 
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